Choriocarcinoma Histologically Mimicking Epithelioid Trophoblastic Tumor – A Diagnostic Pitfall in Gestational Trophoblastic Neoplasia
Authors:
- Ali HarsonoAHAli Harsono
- Aisyah NisaANAisyah Nisa
- Artha SusiloArtha Susilo
- Rommy KurniawanRKRommy Kurniawan
- Gatot WinarnoGatot Winarno
Open Access
- 1 May 2026
- journal article
- case report
- Published by Taylor & Francis in International Journal of Women's Health
- Vol. ume 18, 1-9
Abstract
Background: Histopathological diagnosis can be challenging because epithelioid trophoblastic tumor (ETT) may closely mimic choriocarcinoma, particularly due to overlapping cytologic and architectural features of intermediate trophoblasts. Therefore, immunohistochemical studies are essential for accurate classification of GTN subtypes. Case Illustration: A 27-year-old woman, para 4 abortion 1, with a history of two curettage procedures for partial hydatidiform mole, presented with persistent post-curettage vaginal bleeding for five months and was admitted to the emergency department with severe anemia. Serial β-hCG monitoring demonstrated a significant rise, raising suspicion for GTN. Ultrasonography revealed a vesicular pattern, while additional investigations showed no evidence of metastasis. Based on a FIGO score < 7, the patient was classified as low-risk GTN. The patient declined chemotherapy and opted for total hysterectomy with bilateral salpingectomy. Intraoperative gross examination revealed an irregular, friable, and necrotic uterine mass consistent with GTN. Initial histopathological evaluation suggested epithelioid trophoblastic tumor; however, further immunohistochemical analysis demonstrated negative p63 expression, high Ki-67 index, and positive β-hCG staining, findings more consistent with choriocarcinoma. Discussion: This case highlights the importance of post-molar β-hCG surveillance as a cornerstone for early GTN diagnosis. The biological differences between ETT and choriocarcinoma have significant therapeutic implications, given the poorer chemotherapy response observed in ETT. Overlapping histopathological features emphasizes that diagnosis cannot rely solely on morphology but requires integration of clinical data, disease latency, β-hCG levels, and an appropriate immunohistochemical panel, particularly p63. Conclusion: Delayed post-molar β-hCG monitoring may lead to GTN progression and increased morbidity. Immunohistochemical examination plays a crucial role in differentiating ETT from choriocarcinoma to ensure accurate diagnosis and appropriate management.Keywords
This publication has 13 references indexed in Scilit:
- Diagnosis and management of gestational trophoblastic disease: 2025 updateInternational Journal of Gynecology & Obstetrics, 2025
- Gestational trophoblastic disease: an updateAbdominal Radiology, 2023
- Epidemiologic study on gestational trophoblastic diseases in JapanJournal of Gynecologic Oncology, 2022
- Clinical features and management of trophoblastic epithelioid tumors: A systematic reviewMedicine, 2022
- Clinical presentation and diagnosis of Gestational Trophoblastic DiseaseBest Practice & Research Clinical Obstetrics & Gynaecology, 2021
- Placental site trophoblastic tumour and epithelioid trophoblastic tumourBest Practice & Research Clinical Obstetrics & Gynaecology, 2021
- Comparison of p63 and p40 Immunohistochemical Stains to Distinguish Epithelioid Trophoblastic Tumor From Other Trophoblastic LesionsInternational Journal of Gynecological Pathology, 2018
- Gestational trophoblastic disease II: classification and management of gestational trophoblastic neoplasiaAmerican Journal of Obstetrics and Gynecology, 2011
- Gestational trophoblastic disease I: epidemiology, pathology, clinical presentation and diagnosis of gestational trophoblastic disease, and management of hydatidiform moleAmerican Journal of Obstetrics and Gynecology, 2010
- Gestational trophoblastic diseaseThe Lancet, 2010